Current Opinion in Infectious Diseases

Papers
(The TQCC of Current Opinion in Infectious Diseases is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era65
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel61
La Crosse virus encephalitis in children60
Skin and soft tissue infections in the elderly52
Strongyloidiasis-related lung involvement: too much of a bad thing48
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV47
Skin and soft tissue infections: swab or biopsy? A diagnostic dilemma43
Corticosteroids for viral central nervous system infections41
Surgical management of cystic echinococcosis of the liver39
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside33
Complexities of cardiomyopathy in septic shock33
From diagnosis to management: current perspectives on congenital cytomegalovirus infection33
Typhoid fever control in the 21st century: where are we now?32
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response31
Tissue resident memory T cells in respiratory infections30
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients30
Editorial introductions30
Viral meningitis and encephalitis: an update30
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management30
Managing cognitive impairment in people with HIV: Erratum28
Resistant herpes simplex virus infections – who, when, and what's new?27
Fusarium species central nervous system infection27
Mpox in people living with HIV26
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies25
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?24
Malaria in pregnancy: baby steps24
Tropical infectious diseases and skin manifestations: a diagnostic framework23
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention22
Tick-borne encephalitis21
Does climate change threaten delivery of HIV care in resource-limited settings?21
Tuberculosis molecular bacterial load assay in the management of tuberculosis21
Editorial introductions20
Appropriate surgical management in skin and soft tissue infections20
Diagnostic stewardship: what impacts antibiotics use?18
Using antibiotics wisely18
Interventions for polyoma virus-associated hemorrhagic cystitis18
Gut microbiome and its clinical implications: exploring the key players in human health17
Diagnostic approach and update on encephalitis17
Recent advances in flavivirus encephalitis17
Haemophilus ducreyi in genital ulcer disease: new developments in an old disease17
CMV antiviral stewardship in transplantation – the next frontier17
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis17
Management of neonates born to mothers with active genital herpes simplex virus infection: an alternative approach17
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV16
Risk stratification for selecting empiric antibiotherapy during and after COVID-1916
The plumbing problem: rising antimicrobial resistance in building water systems16
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles16
Editorial introductions15
The microbiota in respiratory tract infections: from association to intervention15
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-1915
Update on the treatment of chronic pulmonary aspergillosis15
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections15
The secret weapon to reduce multidrug-resistant Gram-negative infections: can vaccines help decrease MDR risk?14
Combatting antimicrobial-resistant Neisseria gonorrhoeae: new antibiotics and the pipeline of antigonococcal therapeutics14
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management14
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities14
Interpreting and managing preservation fluids positive for Gram-negative bacteria14
The microbiome as a biomarker of anal precancerous lesions in people with HIV14
Editorial: Pathogenesis and immune response – editorial14
Childhood tuberculosis14
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential14
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae14
Respiratory metagenomics: route to routine service13
Data science for pediatric infectious disease: utilizing COVID-19 as a model13
Advanced neuroimaging for central nervous system infections: when, where, how, and why?13
Chronic persistent Norovirus in the immune-compromised host13
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans13
Update on drug treatments for multidrug resistant tuberculosis13
Travellers’ diarrhoea – solidifying our knowledgebase13
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients12
Short treatment duration for community-acquired pneumonia12
An overview of risk factors, management and prevention of cochlear implant infections12
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis12
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives12
Identifying patients with difficult-to-treat acute bacterial skin infections11
A new era of HIV care for age-associated multimorbidity11
Anti-inflammatory therapies for bronchiectasis11
The disease burden of respiratory syncytial virus in Infants11
Skin and soft tissue infections in solid organ transplants11
Neurobrucellosis11
Antiviral therapies for respiratory syncytial virus infection: current expectations11
Urinary tract infections in immunocompromised patients11
Short-course antibiotic strategies for ventilator-associated pneumonia11
Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients10
Genetic mechanisms underlying host susceptibility to central nervous system viral infections10
Burden of influenza in the elderly: a narrative review10
Updates on the neurological manifestations of SARS-CoV-2 infection10
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities10
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention9
Endemic viral infections in immunocompromised hosts: Dengue, Chikungunya, Zika9
Live vaccines in solid organ transplant recipients9
Chagas disease in the immunocompromised host9
Therapeutic agents for the treatment of human mpox9
Immune responses and severe dengue: what have we learned?9
Effective strategies for managing trimethoprim-sulfamethoxazole and levofloxacin-resistant Stenotrophomonas maltophilia infections: bridging the gap between scientific evidence and clinical practice9
The evolution of knowledge for treating Gram-negative bacterial infections9
Genome-wide approaches to bacterial strain typing: a history and review of recent methodological advances9
Duration of antibiotic therapy in Gram-negative infections with a particular focus on multidrug-resistant pathogens9
Surgical site infection prophylaxis: what have we learned and are we making progress?9
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity9
1.3438401222229